This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
The biotechnology industry is home to 50 unicorn startups pursuing a wide range of scientific goals. These companies are developing new technologies for everything from tissue regeneration to de-extinction.
The sector includes major players like Biosplice Therapeutics, valued at $12 billion. It also features companies like Neuralink, which has raised $1.3 billion to build brain-computer interfaces.
Below is the full list of 50 Biotechnology unicorn startups at this time.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Biosplice Therapeutics develops first-in-class, small-molecule drugs based on the science of alternative splicing. Their clinical pipeline focuses on treating major diseases, including a lead candidate for osteoarthritis and other programs in oncology.
Neuralink develops implantable brain-computer interfaces designed to connect the human brain directly to computers. The technology's first application aims to give people with paralysis the ability to control digital devices with their thoughts alone.
Colossal Biosciences pioneers de-extinction using advanced biotechnology and genetic engineering. Their primary mission involves using gene editing technologies to resurrect extinct species, most notably the Woolly Mammoth.
Benchling builds the R&D Cloud, a unified software platform designed for scientists and biotechnology organizations. Their system helps centralize complex scientific data, allowing research teams to collaborate more effectively and bring new products to market faster.
Biocon Biologics develops and manufactures high-quality, affordable biosimilars for patients across the globe. The company focuses on complex therapies in areas like diabetes, oncology, and immunology to expand access to critical treatments.
Color provides the healthcare infrastructure for employers, health plans, and governments to deliver care programs to their populations. Their platform focuses on making services like cancer screening and prevention more accessible through at-home diagnostics and virtual-first care.
Sinovac Life Sciences researches, develops, and manufactures human vaccines. As a research-based company, they manage the entire product lifecycle from initial studies through to commercial sales.
Freenome develops blood tests for early cancer detection using a comprehensive multiomics platform. These tests are designed to make routine screening more accessible through a simple blood draw.
Insitro applies machine learning and high-throughput biology to rethink the drug discovery and development process. Their platform generates massive datasets to build predictive models of disease, aiming to uncover new therapeutic solutions.
Inari develops seeds for a more sustainable food system using its proprietary SEEDesign™ platform. The resulting seeds are engineered to significantly increase yields while reducing the need for water and fertilizer.
The top 10 companies only scratch the surface of what's happening in biotechnology. Founders around the world are tackling big problems in health and science.
Many of these startups are in the United States, but companies in China, Japan, and India are also growing quickly. Here’s a look at the other unicorns shaping the future of biotech.
| Unicorn Startup | Country | Year Founded | Amount Raised | Valuation |
|---|---|---|---|---|
| United States | 2023 | $1B | $2.15B | |
| United States | 2011 | $616.9M | $2B | |
| United States | 2018 | $300M | $2B | |
| United States | 2018 | $623.1M | $2B | |
| United States | 2019 | $321M | $2B | |
| United States | 2019 | $921.3M | $2B | |
| United States | 2014 | $240M | $2B | |
| United States | 2020 | $447M | $2B | |
| Japan | 2014 | ¥44.6B | $2B | |
| United States | 2014 | $801.5M | $2B | |
| India | 2000 | $117.5M | $2B | |
| United States | 2016 | $855.8M | $2B | |
| China | 2016 | CN¥5.6B | $2B | |
| United States | 2012 | $719.1M | $2B | |
| United States | 2012 | $250.8M | $2B | |
| United States | 2018 | $693M | $1.36B | |
| Japan | 2007 | $976.1M | $1.22B | |
| United States | 2016 | $425.9M | $1B | |
| United States | 2014 | $624.3M | $1B | |
| United States | 2016 | $600M | $1B | |
| United States | 2017 | $678M | $1B | |
| United States | 2020 | $3.4B | $1B | |
| United States | 2019 | $529.9M | $1B | |
| United States | 2018 | $295M | $1B | |
| United States | 2013 | $369.8M | $1B | |
| United States | 2015 | CN¥410M | $1B | |
| United States | 2016 | $304.1M | $1B | |
| India | 2001 | $184.2M | $1B | |
| United States | 2015 | $50.6M | $1B | |
| United States | 1998 | $257M | $1B | |
| United States | 2017 | $359.5M | $1B | |
| China | 2016 | $425.8M | $1B | |
| United States | 2011 | $465M | $1B | |
| United States | 2013 | $528M | $1B | |
| United States | 2015 | $708M | $1B | |
| China | 2016 | CN¥2B | $1B | |
| China | 2018 | $204M | $1B | |
| China | 2011 | $317.6M | $1B | |
| China | 2015 | $200M | $1B | |
| China | 2016 | CN¥200M | $1B |
